Regulation of muscle transcription by the MyoD family. The heart of the matter.

The two striated muscle cell types, skeletal and cardiac muscle, express overlapping sets of muscle-specific genes. Activation of muscle-specific transcription in skeletal muscle is controlled by the MyoD family of regulatory factors, which are expressed exclusively in skeletal muscle. Members of the MyoD family share homology within a basic helix-loop-helix (HLH) motif that mediates DNA binding and dimerization and form heterodimers with widely expressed HLH proteins, referred to as E proteins. Although many of the genes that are regulated by members of the MyoD family are also expressed in cardiac muscle, known members of the MyoD family have never been detected in cardiac muscle, suggesting that cardiac myocytes either express unique cell type-specific HLH proteins or rely on a distinct regulatory strategy for activation of cardiac muscle transcription. This review will summarize current knowledge of the mechanisms through which the MyoD family activates skeletal muscle transcription and will consider potential mechanisms that may regulate gene expression in the heart.

[1]  J. Mar,et al.  Characterization of a promoter element required for transcription in myocardial cells. , 1991, The Journal of biological chemistry.

[2]  K. Chien,et al.  A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression , 1992, Molecular and cellular biology.

[3]  J. Shryock,et al.  Selective A2-adenosine receptor agonists do not alter action potential duration, twitch shortening, or cAMP accumulation in guinea pig, rat, or rabbit isolated ventricular myocytes. , 1993, Circulation research.

[4]  J. Leiden,et al.  The structure and regulation of expression of the murine fast skeletal troponin C gene. Identification of a developmentally regulated, muscle-specific transcriptional enhancer. , 1990, The Journal of biological chemistry.

[5]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[6]  E. Olson,et al.  MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. , 1992, Development.

[7]  Robert K. Davis,et al.  The myoD gene family: nodal point during specification of the muscle cell lineage. , 1991, Science.

[8]  N. Toda,et al.  Impairment by damage of the pterygopalatine ganglion of nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. , 1993, Circulation research.

[9]  J. Mar,et al.  A conserved CATTCCT motif is required for skeletal muscle-specific activity of the cardiac troponin T gene promoter. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Parker,et al.  Cardiac growth factors. , 1991, Progress in growth factor research.

[11]  H. Weintraub,et al.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation , 1990, Cell.

[12]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[13]  E. Olson.  MyoD family: a paradigm for development? , 1990, Genes & development.

[14]  M. Allard,et al.  Regional myocardial capillary erythrocyte transit time in the normal resting heart. , 1993, Circulation research.

[15]  B. Wold,et al.  Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. , 1992, Development.

[16]  I. Cohen,et al.  Pacemaker current exists in ventricular myocytes. , 1993, Circulation research.

[17]  R. Treisman,et al.  Human SRF-related proteins: DNA-binding properties and potential regulatory targets. , 1991, Genes & development.

[18]  B. Nadal-Ginard,et al.  Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. , 1992, Genes & development.

[19]  D. Goldhamer,et al.  Identification of DNA-binding protein(s) in the developing heart. , 1993, Developmental biology.

[20]  B. Nadal-Ginard,et al.  A MyoD1-independent muscle-specific enhancer controls the expression of the beta-myosin heavy chain gene in skeletal and cardiac muscle cells. , 1991, The Journal of biological chemistry.

[21]  J. Martín,et al.  Analysis of the oligomerization of myogenin and E2A products in vivo using a two-hybrid assay system. , 1992, The Journal of biological chemistry.

[22]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[23]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[24]  A. Fire,et al.  Body-wall muscle formation in Caenorhabditis elegans embryos that lack the MyoD homolog hlh-1. , 1992, Science.

[25]  E. Olson,et al.  Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Kedes,et al.  Myocardial activation of the human cardiac alpha-actin promoter by helix-loop-helix proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.